Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cécile Luxembourger"'
Autor:
Adeline Ruyssen-Witrand, Cécile Luxembourger, Alain Cantagrel, Delphine Nigon, Pascal Claudepierre, Yannick Degboe, Arnaud Constantin
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-8 (2019)
Abstract Background To investigate the association between 12 single nucleotide polymorphisms (SNPs) located on ERAP1 and IL23R with the presence of inflammation on the sacroiliac joint (SIJ) or spinal magnetic resonance imagery (MRI) in an early ons
Externí odkaz:
https://doaj.org/article/5bdc039d6c874e71aa84f04198847e69
Autor:
Cécile Luxembourger, Pascal Claudepierre, Arnaud Constantin, Delphine Nigon, Alain Cantagrel, Yannick Degboé, Adeline Ruyssen-Witrand
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-8 (2019)
Arthritis Research & Therapy
Arthritis Research & Therapy, 2019, 21 (1), pp.22. ⟨10.1186/s13075-018-1807-5⟩
Arthritis Research & Therapy
Arthritis Research & Therapy, 2019, 21 (1), pp.22. ⟨10.1186/s13075-018-1807-5⟩
Background To investigate the association between 12 single nucleotide polymorphisms (SNPs) located on ERAP1 and IL23R with the presence of inflammation on the sacroiliac joint (SIJ) or spinal magnetic resonance imagery (MRI) in an early onset spondy
Autor:
Bertrand Lioger, Aurélien Marabelle, Stéphane Champiat, Arsène Mekinian, Jean-Marie Michot, Olivier Fain, Anne-Laure Voisin, Rakiba Belkhir, Caroline Robert, Sébastien Le Burel, Jean-Charles Soria, Olivier Lambotte, Laetitia Dunogeant, Christine Mateus, Xavier Mariette, Tali-Anne Szwebel, Cécile Luxembourger, Salim Laghouati, Laetitia Coutte
Publikováno v:
European Journal of Cancer. 82:34-44
Aim The growing use of immune checkpoint inhibitors (ICIs) is associated with the occurrence of immune-related adverse events (irAEs). Few data are published on systemic, immunohaematological and rheumatic irAEs. In a pharmacovigilance database analy
Autor:
Jean-Francis Maillefert, Daniel Wendling, Yannick Degboé, Isabelle Touitou, Cécile Rittore, Hubert Marotte, Chayma Ladhari, Alain Cantagrel, Arnaud Constantin, Delphine Nigon, Cécile Luxembourger, Jacques-Eric Gottenberg, Yves-Marie Pers, Adeline Ruyssen-Witrand, Christian Jorgensen, Philippe Gaudin
Publikováno v:
Pharmacogenomics Journal
Pharmacogenomics Journal, Nature Publishing Group, 2019, 19 (4), pp.368--374. ⟨10.1038/s41397-019-0072-6⟩
Pharmacogenomics Journal, Nature Publishing Group, 2019, 19 (4), pp.368--374. ⟨10.1038/s41397-019-0072-6⟩
International audience; Biological disease-modifying anti-rheumatic drugs (bDMARDs) have changed care of patients with rheumatoid arthritis (RA). However, bDMARDs are costly, can lead to serious infections, and induce a sustained remission in only 30
Autor:
Bernard Combe, Olivier Vittecoq, Alain Cantagrel, Philippe Gaudin, Maxime Dougados, Pascal Richette, Thierry Schaeverbeke, Isabelle Pane, Xavier Mariette, Philippe Ravaud, Jacques-Eric Gottenberg, René-Marc Flipo, Raphaèle Seror, Jérémie Sellam, Jean Sibilia, P. Lafforgue, Cécile Luxembourger, Pascal Claudepierre, Augustin Latourte
Publikováno v:
Rheumatology
Rheumatology, Oxford University Press (OUP), 2017, 56 (4), pp.629-637. ⟨10.1093/rheumatology/kew476⟩
Rheumatology, Oxford University Press (OUP), 2017, 56 (4), pp.629-637. ⟨10.1093/rheumatology/kew476⟩
International audience; Objective:To investigate the frequency and risk factors of postoperative complications in RA patients treated with abatacept (ABA).Methods:The Orencia RA registry recruited 1012 patients receiving ABA for RA in routine care. D
Autor:
Sophie Fournier, Jacques Izopet, Laurent Messer, Béatrice Pallot-Prades, Anna Molto, Anne-Marie Roque-Afonso, Florence Abravanel, Christelle Sordet, Cécile Luxembourger, Jacques-Eric Gottenberg, Emmanuel Chatelus, Pascal Claudepierre, Jean Sibilia, Martin Soubrier, Alain Cantagrel, Sylvie Fabre, Yves-Marie Pers, Christian Roux, Hélène Bauer, Daniel Wendling, Christophe Hudry, Claire Veissier, Laurent Marguerie, Guillaume Lefèvre, Jean-Marie Péron, Antoine Martin
Publikováno v:
Medicine. 94:e675
The clinical presentation and outcome of hepatitis E virus (HEV) infection in inflammatory rheumatic diseases are unknown. We aimed to investigate the severity of acute HEV infection and the risk of chronic viral replication in patients with inflamma